Efficacy of ixekizumab in patients with moderate-to-severe plaque psoriasis and prediabetes or type 2 diabetes

OBJECTIVE: Patients with psoriasis have an increased prevalence of type 2 diabetes when compared to the general population. Research suggests that type 2 diabetes (T2D) as well as obesity may have an impact on patients' response to treatment. This post-hoc analysis reports the efficacy of ixeki...

Descripción completa

Detalles Bibliográficos
Autores principales: Egeberg, Alexander, Merola, Joseph F., Schäkel, Knut, Puig, Luis, Mahar, Patrick D., Wang, Isabella Yali, Pavo, Imre, Schuster, Christopher, Griffiths, Christopher E. M.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Frontiers Media S.A. 2023
Materias:
Medicine
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912352/
https://www.ncbi.nlm.nih.gov/pubmed/36777159
http://dx.doi.org/10.3389/fmed.2022.1092688

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9912352/
https://www.ncbi.nlm.nih.gov/pubmed/36777159
http://dx.doi.org/10.3389/fmed.2022.1092688

Ejemplares similares